Resultados: 604

    CDC recommendations for hepatitis C testing among perinatally exposed infants and children: United States, 2023

    MMWR recomm. rep; 72 (4), 2023
    The elimination of hepatitis C is a national priority (https://www.hhs.gov/sites/default/files/Viral-Hepatitis-NationalStrategic-Plan-2021-2025.pdf). During 2010–2021, hepatitis C virus (HCV) acute and chronic infections (hereinafter referred to as HCV infections) increased in the United States, conseq...

    Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up

    Ann. oncol; 34 (11), 2023
    The opportunity to detect pancreatic cancer (PC) when potentially curable depends on early diagnosis and an ability to identify and screen high-risk populations before symptoms arise. Identification of a high-risk population is challenging and optimal screening tools remain unclear.1 Older age is the str...

    Recurrent miscarriage: green-top guideline nº 17

    BJOG; 130 (12), 2023
    The purpose of this guideline is to provide guidance on the investigation and care of women and people with recurrent miscarriage.Within this document we use the terms woman and women's health. However, it is important to acknowledge that it is not only women for whom it is necessary to ...

    Antiplatelets and antithrombotics in neurointerventional procedures: guideline update

    J Neurointerv Surg; 15 (11), 2023
    Antiplatelet and antithrombotic medication management before, during, and after neurointerventional procedures has significant practice variation. This document updates and builds upon the 2014 Society of NeuroInterventional Surgery (SNIS) Guideline ’Platelet function inhibitor and platelet function te...

    Compounded bioidentical menopausal hormone therapy ACOG clinical consensus nº 6

    Obstet. gynecol; 142 (5), 2023
    Many compounding pharmacies use the phrase “bioidentical hormone” as a marketing term to imply that these preparations are natural and, thus, safer and more effective than U.S. Food and Drug Administration (FDA)–approved menopausal medications that use bioidentical or synthetic hormones or both. Ho...

    AGA clinical practice update on risk stratification for colorectal cancer screening and post-polypectomy surveillance: expert review

    Gastroenterology; 165 (5), 2023
    Since the early 2000s, there has been a rapid decline in colorectal cancer (CRC) mortality, due in large part to screening and removal of precancerous polyps. Despite these improvements, CRC remains the second leading cause of cancer deaths in the United States, with approximately 53,000 deaths projected...

    AGA clinical practice update on the epidemiology, evaluation, and management of exocrine pancreatic insufficiency: expert review

    Gastroenterology; 165 (5), 2023
    Exocrine pancreatic insufficiency (EPI) is a disorder caused by the failure of the pancreas to deliver a minimum/ threshold level of specific pancreatic digestive enzymes to the intestine, leading to the maldigestion of nutrients and macronutrients, resulting in their variable deficiencies. EPI is freque...

    2023 American Heart Association focused update on the management of patients with cardiac arrest or life-threatening toxicity due to poisoning: an update to the American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care

    Circulation; 148 (16), 2023
    In this focused update, the American Heart Association provides updated guidance for resuscitation of patients with cardiac arrest, respiratory arrest, and refractory shock due to poisoning. Based on structured evidence reviews, guidelines are provided for the treatment of critical ...

    European Respiratory Society short guidelines for the use of as-needed ICS/formoterol in mild asthma

    Eur. respir. j; 62 (), 2023
    Recent clinical trials of as-needed fixed-dose combination of inhaled corticosteroid (ICS)/formoterol have provided new evidence that may warrant a reconsideration of current practice. A Task Force was set up by the European Respiratory Society to provide evidence-based recommendations on the use of as-n...

    Duration of antimicrobial treatment for complicated intra-abdominal infections after definitive source control: A systematic review, meta-analysis, and practice management guideline from the Eastern Association for the Surgery of Trauma

    J. trauma; 95 (4), 2023
    Recent studies have evaluated outcomes associated with duration of antimicrobial treatment for complicated intra-abdominal infections (cIAI). The goal of this guideline was to help clinicians better define appropriate antimicrobial duration in patients who have undergone definitive source control for cIA...